277 related articles for article (PubMed ID: 21807103)
1. Hyperpolarized 13C MR spectroscopic imaging can be used to monitor Everolimus treatment in vivo in an orthotopic rodent model of glioblastoma.
Chaumeil MM; Ozawa T; Park I; Scott K; James CD; Nelson SJ; Ronen SM
Neuroimage; 2012 Jan; 59(1):193-201. PubMed ID: 21807103
[TBL] [Abstract][Full Text] [Related]
2. Noninvasive detection of target modulation following phosphatidylinositol 3-kinase inhibition using hyperpolarized 13C magnetic resonance spectroscopy.
Ward CS; Venkatesh HS; Chaumeil MM; Brandes AH; Vancriekinge M; Dafni H; Sukumar S; Nelson SJ; Vigneron DB; Kurhanewicz J; James CD; Haas-Kogan DA; Ronen SM
Cancer Res; 2010 Feb; 70(4):1296-305. PubMed ID: 20145128
[TBL] [Abstract][Full Text] [Related]
3. MR Studies of Glioblastoma Models Treated with Dual PI3K/mTOR Inhibitor and Temozolomide:Metabolic Changes Are Associated with Enhanced Survival.
Radoul M; Chaumeil MM; Eriksson P; Wang AS; Phillips JJ; Ronen SM
Mol Cancer Ther; 2016 May; 15(5):1113-22. PubMed ID: 26883274
[TBL] [Abstract][Full Text] [Related]
4. Reduced phosphocholine and hyperpolarized lactate provide magnetic resonance biomarkers of PI3K/Akt/mTOR inhibition in glioblastoma.
Venkatesh HS; Chaumeil MM; Ward CS; Haas-Kogan DA; James CD; Ronen SM
Neuro Oncol; 2012 Mar; 14(3):315-25. PubMed ID: 22156546
[TBL] [Abstract][Full Text] [Related]
5. Hyperpolarized (13)C MR imaging detects no lactate production in mutant IDH1 gliomas: Implications for diagnosis and response monitoring.
Chaumeil MM; Radoul M; Najac C; Eriksson P; Viswanath P; Blough MD; Chesnelong C; Luchman HA; Cairncross JG; Ronen SM
Neuroimage Clin; 2016; 12():180-9. PubMed ID: 27437179
[TBL] [Abstract][Full Text] [Related]
6. HDAC inhibition in glioblastoma monitored by hyperpolarized
Radoul M; Najac C; Viswanath P; Mukherjee J; Kelly M; Gillespie AM; Chaumeil MM; Eriksson P; Delos Santos R; Pieper RO; Ronen SM
NMR Biomed; 2019 Feb; 32(2):e4044. PubMed ID: 30561869
[TBL] [Abstract][Full Text] [Related]
7. Correlation of Tumor Perfusion Between Carbon-13 Imaging with Hyperpolarized Pyruvate and Dynamic Susceptibility Contrast MRI in Pre-Clinical Model of Glioblastoma.
Park I; Lupo JM; Nelson SJ
Mol Imaging Biol; 2019 Aug; 21(4):626-632. PubMed ID: 30225760
[TBL] [Abstract][Full Text] [Related]
8. Hyperpolarized [1-
Esfahani SA; Callahan C; Rotile NJ; Heidari P; Mahmood U; Caravan PD; Grant AK; Yen YF
Mol Imaging Biol; 2022 Oct; 24(5):769-779. PubMed ID: 35467249
[TBL] [Abstract][Full Text] [Related]
9. Detection of early response to temozolomide treatment in brain tumors using hyperpolarized 13C MR metabolic imaging.
Park I; Bok R; Ozawa T; Phillips JJ; James CD; Vigneron DB; Ronen SM; Nelson SJ
J Magn Reson Imaging; 2011 Jun; 33(6):1284-90. PubMed ID: 21590996
[TBL] [Abstract][Full Text] [Related]
10. Hyperpolarized 13C magnetic resonance metabolic imaging: application to brain tumors.
Park I; Larson PE; Zierhut ML; Hu S; Bok R; Ozawa T; Kurhanewicz J; Vigneron DB; Vandenberg SR; James CD; Nelson SJ
Neuro Oncol; 2010 Feb; 12(2):133-44. PubMed ID: 20150380
[TBL] [Abstract][Full Text] [Related]
11. Hyperpolarized
Guglielmetti C; Najac C; Didonna A; Van der Linden A; Ronen SM; Chaumeil MM
Proc Natl Acad Sci U S A; 2017 Aug; 114(33):E6982-E6991. PubMed ID: 28760957
[TBL] [Abstract][Full Text] [Related]
12. PTEN loss does not predict for response to RAD001 (Everolimus) in a glioblastoma orthotopic xenograft test panel.
Yang L; Clarke MJ; Carlson BL; Mladek AC; Schroeder MA; Decker P; Wu W; Kitange GJ; Grogan PT; Goble JM; Uhm J; Galanis E; Giannini C; Lane HA; James CD; Sarkaria JN
Clin Cancer Res; 2008 Jun; 14(12):3993-4001. PubMed ID: 18559622
[TBL] [Abstract][Full Text] [Related]
13. Multi-parametric hyperpolarized
Autry AW; Vaziri S; LaFontaine M; Gordon JW; Chen HY; Kim Y; Villanueva-Meyer JE; Molinaro A; Clarke JL; Oberheim Bush NA; Xu D; Lupo JM; Larson PEZ; Vigneron DB; Chang SM; Li Y
Neuroimage Clin; 2023; 39():103501. PubMed ID: 37611371
[TBL] [Abstract][Full Text] [Related]
14. Multimodal assessment of in vivo metabolism with hyperpolarized [1-13C]MR spectroscopy and 18F-FDG PET imaging in hepatocellular carcinoma tumor-bearing rats.
Menzel MI; Farrell EV; Janich MA; Khegai O; Wiesinger F; Nekolla S; Otto AM; Haase A; Schulte RF; Schwaiger M
J Nucl Med; 2013 Jul; 54(7):1113-9. PubMed ID: 23596002
[TBL] [Abstract][Full Text] [Related]
15. Offset of apparent hyperpolarized
Choi YS; Lee J; Lee HS; Song JE; Kim DH; Song HT
NMR Biomed; 2021 Aug; 34(8):e4561. PubMed ID: 34080736
[TBL] [Abstract][Full Text] [Related]
16. Combining Hyperpolarized Real-Time Metabolic Imaging and NMR Spectroscopy To Identify Metabolic Biomarkers in Pancreatic Cancer.
Dutta P; Perez MR; Lee J; Kang Y; Pratt M; Salzillo TC; Weygand J; Zacharias NM; Gammon ST; Koay EJ; Kim M; McAllister F; Sen S; Maitra A; Piwnica-Worms D; Fleming JB; Bhattacharya PK
J Proteome Res; 2019 Jul; 18(7):2826-2834. PubMed ID: 31120258
[TBL] [Abstract][Full Text] [Related]
17. Dual inhibition of PFKFB3 and VEGF normalizes tumor vasculature, reduces lactate production, and improves chemotherapy in glioblastoma: insights from protein expression profiling and MRI.
Zhang J; Xue W; Xu K; Yi L; Guo Y; Xie T; Tong H; Zhou B; Wang S; Li Q; Liu H; Chen X; Fang J; Zhang W
Theranostics; 2020; 10(16):7245-7259. PubMed ID: 32641990
[No Abstract] [Full Text] [Related]
18. Reversed metabolic reprogramming as a measure of cancer treatment efficacy in rat C6 glioma model.
Datta K; Lauritzen MH; Merchant M; Jang T; Liu SC; Hurd R; Recht L; Spielman DM
PLoS One; 2019; 14(12):e0225313. PubMed ID: 31830049
[TBL] [Abstract][Full Text] [Related]
19. Imaging Glioblastoma Metabolism by Using Hyperpolarized [1-
Zaccagna F; McLean MA; Grist JT; Kaggie J; Mair R; Riemer F; Woitek R; Gill AB; Deen S; Daniels CJ; Ursprung S; Schulte RF; Allinson K; Chhabra A; Laurent MC; Locke M; Frary A; Hilborne S; Patterson I; Carmo BD; Slough R; Wilkinson I; Basu B; Wason J; Gillard JH; Matys T; Watts C; Price SJ; Santarius T; Graves MJ; Jefferies S; Brindle KM; Gallagher FA
Radiol Imaging Cancer; 2022 Jul; 4(4):e210076. PubMed ID: 35838532
[TBL] [Abstract][Full Text] [Related]
20. Metabolic Imaging Detects Low Levels of Glycolytic Activity That Vary with Levels of c-Myc Expression in Patient-Derived Xenograft Models of Glioblastoma.
Mair R; Wright AJ; Ros S; Hu DE; Booth T; Kreis F; Rao J; Watts C; Brindle KM
Cancer Res; 2018 Sep; 78(18):5408-5418. PubMed ID: 30054337
[No Abstract] [Full Text] [Related]
[Next] [New Search]
